Group 1 - The core viewpoint of the article highlights the performance of Meihao Medical, which closed at 28.87 yuan, up 1.55%, with a rolling PE ratio of 43.31 times, marking a new low in 11 days, and a total market capitalization of 11.74 billion yuan [1] - In terms of industry comparison, the average PE ratio for the medical device sector is 44.91 times, with a median of 31.89 times, placing Meihao Medical at the 84th position in the industry ranking [1] - As of March 10, 2025, the number of shareholders for Meihao Medical increased to 8,647, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Group 2 - Meihao Medical specializes in the design, development, manufacturing, and sales of precision components and products for medical devices, including home ventilator components and cochlear implant components [1] - The latest financial results for the third quarter of 2024 show that the company achieved a revenue of 1.157 billion yuan, a year-on-year increase of 10.86%, while net profit was 258 million yuan, reflecting a year-on-year decrease of 14.07%, with a gross profit margin of 41.78% [1]
美好医疗收盘上涨1.55%，滚动市盈率43.31倍，总市值117.40亿元